| 1 |
Lee HC, Kim M, Wands JR. Wnt/Frizzled signaling in hepatocellular carcinoma. Front Biosci, 2006,11: 1901-1915.
|
| 2 |
Kim M, Lee HC, Tsedensodnom O, et al. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol, 2008, 48(5): 780-791.
|
| 3 |
Yuzugullu H, Benhaj K, Ozturk N, et al. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Molecular Cancer, 2009, 8: 90.
|
| 4 |
Lee TH, Tai DI, Cheng CJ, et al. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics. J Biomed Sci, 2006, 13(1): 27-39.
|
| 5 |
Lee HH, Uen YH, Tian YF, et al. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery. Cancer Epidemiol.Biomarkers Prev, 2009, 18(5): 1562-1569
|
| 6 |
Yoshikawa H, Matsubara K, Zhou X, et al. WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer. Mol Biol Cell, 2007, 18(11): 4292-4303.
|
| 7 |
Bengochea A, de Souza MM, Lefrancois L, et al. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer, 2008, 99(1): 143-150.
|
| 8 |
Merle P, Kim M, Herrmann M, et al. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. J Hepatol, 2005, 43(5): 854-862.
|
| 9 |
Mao B, Niehrs C. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene, 2003, 302(1/2): 179-183.
|
| 10 |
Wehrli M, Dougan ST, Caldwell K, et al. Arrow encodes an LDL-receptor-related protein essential for wingless signalling. Nature, 2000, 407(6803): 527-530.
|
| 11 |
Uematsu K, He B, You L, et al. Activation of the wnt pathway in non small cell lung cancer:evidence of disheveled overexpression. Oncogene, 2003, 22(46): 7218-7221
|
| 12 |
Colnot S, Decaens T, Niwa-Kawakita M, et al. Liver-targeted disruption of Apc in mice activates beta—catenin signaling and leads to heDatoceUular carcinomas. Proc Natl Acad Sci USA, 2004, 101(49): 17 216-17 221.
|
| 13 |
Harder J, Opitz OG, Brabender J, et al. Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver. Int J Cancer, 2008, 122(12): 2800-2804.
|
| 14 |
白同, 杨斌, 娄诚, 等. APC和CDKN2A基因甲基化定量分析对肝细胞癌的诊断价值. 世界华人消化杂志, 2009, 17(29): 3001-3007.
|
| 15 |
Satoh S, Daigo Y, Furukawa Y, et al. AXINI mutations in hapatocellualr carcinomas，and growth suppression in cancer cells by virus-mediated transfer of AXINI. Nat Genet, 2000, 24(3): 245-250.
|
| 16 |
Rui Y, Xu Z, Lin S, et al. Axin stimulates p53 functions by activation of kinase through multimetric complex formation. EMBO J, 2004, 23(23): 4583-4594.
|
| 17 |
Neo SY, Zhang Y, Yaw LP, et al. Axin-induced apoptosis depends on the extent of its JNK activation and its ability to down-regulate beta-catenin levels. Biochem Biophys Res Commun, 2000, 272(1): 144-150.
|
| 18 |
刘树立, 徐洪涛, 杨连赫, 等. Axin过表达下调β-catenin和TCF-4表达并抑制肺癌BE1细胞的增殖和侵袭. 中国肺癌杂志, 2009，12(4):277-282
|
| 19 |
Ishizaki Y, Ikeda S, Fujimori M, et al. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol, 2004, 24(5): 1077-1083.
|
| 20 |
Satoh S, Daigo Y, Furukawa Y, et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet, 2000, 24(3): 245-250.
|
| 21 |
Desbois-mouthon C, Blivet-Van Eggelpoёl MJ, Beurel E, et al. Dysregulation of glycogen synthase kinase-3 beta signaling in hepatocellualar carcinoma cells. Hepatology, 2002, 36(6): 1528-1536.
|
| 22 |
Ding Q, Xia W, Liu JC, et al. Erk associates with and primes GSK- 3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell, 2005, 19(2): 159-170.
|
| 23 |
Leoppen S, Koehle C, Buchmann A, et al. A beta-catenin dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis, 2005, 26(1): 239-248.
|
| 24 |
Lian Z, Liu J, Li L, et al. Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology, 2006, 43(3): 415-424.
|
| 25 |
Pan J, Lian Z, Wallett S, et al. The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin. J Gen Virol, 2007, 88(Pt 12): 3275-3285.
|
| 26 |
Zeng G, Apte U, Cieply B, et al. siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia, 2007, 9(11): 951-959.
|
| 27 |
Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta, 2003, 1653(1): 1-24.
|
| 28 |
Yuzugullu H, Benhaj K, Ozturk N, et al. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer, 2009, 8: 90.
|
| 29 |
Barker N, Huls G, Korinek V, et al. Restricted high level expression of TCF-4 protein in intestinal and mammary gland epithelium. An J Pathol, 1999, 154(1): 29-35.
|
| 30 |
Zhao DH, Hong JJ, Guo SY, et al. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Cell Res, 2004, 14(1): 74-80.
|
| 31 |
Graham TA, Weaver C, Mao F, et al. Crystal structure of a beta- catenin/Tcf complex. Cell, 2000,103(6): 885-896.
|
| 32 |
Thorstensen L, Lind GE, Lovig T, et al. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia, 2005, 7(2): 99-108.
|